Joachim Sieper

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 29

Top Topics

Ankylosing Spondylitis

Endoplasmic Reticulum

Disease Activity

Spinal Cord Injury

Top Venues

Annals of the rheumatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Clara Mistegård Jørgensen, Anne Troldborg, Anne Gitte Loft, Steffen Thiel, Laura Spiller, Mikhail Protopopov, Valeria Rios Rodriguez, Burkhard Muche, Judith Rademacher, Anne-Katrin Weber, Susanne Lüders, Joachim Sieper, Denis Poddubnyy, Fabian Proft
Exploring complement biomarkers in suspected axial spondyloarthritis. RMD open 10 (2) (2024)
Fabian Proft, Murat Torğutalp, Burkhard Muche, Valeria Rios Rodriguez, Joachim Listing, Mikhail Protopopov, Judith Rademacher, Hildrun Haibel, Laura Spiller, Anne-Katrin Weber, Maryna Verba, Jan Brandt-Juergens, Uta Kiltz, Maren Sieburg, Swen Jacki, Joachim Sieper, Denis Poddubnyy
Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial. Annals of the rheumatic diseases (2024)
Fares Al Mohamad, Valeria Rios Rodriguez, Hildrun Haibel, Mikhail Protopopov, Judith Rademacher, Joachim Sieper, Murat Torğutalp, Henriette Käding, Fabian Proft, Denis Poddubnyy
Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs. RMD open 10 (1) (2024)
Fabian Proft, Murat Torğutalp, Burkhard Muche, Valeria Rios Rodriguez, Joachim Listing, Mikhail Protopopov, Judith Rademacher, Hildrun Haibel, Laura Spiller, Anne-Katrin Weber, Maryna Verba, Jan Brandt-Juergens, Uta Kiltz, Maren Sieburg, Swen Jacki, Joachim Sieper, Denis Poddubnyy
Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial. Annals of the rheumatic diseases 83 (5) (2024)
Fabian Proft, Murat Torğutalp, Burkhard Muche, Valeria Rios Rodriguez, Joachim Listing, Mikhail Protopopov, Judith Rademacher, Hildrun Haibel, Laura Spiller, Anne-Katrin Weber, Maryna Verba, Jan Brandt-Juergens, Uta Kiltz, Maren Sieburg, Swen Jacki, Joachim Sieper, Denis Poddubnyy
Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial. Annals of the rheumatic diseases 83 (5) (2024)
Fares Al Mohamad, Valeria Rios Rodriguez, Hildrun Haibel, Mikhail Protopopov, Judith Rademacher, Joachim Sieper, Murat Torğutalp, Henriette Käding, Fabian Proft, Denis Poddubnyy
Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs. RMD open 10 (1) (2024)
Fares Al Mohamad, Valeria Rios Rodriguez, Hildrun Haibel, Mikhail Protopopov, Judith Rademacher, Joachim Sieper, Murat Torğutalp, Henriette Käding, Fabian Proft, Denis Poddubnyy
Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs. RMD open 10 (1) (2024)
Fares Al Mohamad, Valeria Rios Rodriguez, Hildrun Haibel, Mikhail Protopopov, Judith Rademacher, Joachim Sieper, Murat Torğutalp, Henriette Käding, Fabian Proft, Denis Poddubnyy
Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs. RMD open 10 (1) (2024)
Clara Mistegård Jørgensen, Anne Troldborg, Anne Gitte Loft, Steffen Thiel, Laura Spiller, Mikhail Protopopov, Valeria Rios Rodriguez, Burkhard Muche, Judith Rademacher, Anne-Katrin Weber, Susanne Lüders, Joachim Sieper, Denis Poddubnyy, Fabian Proft
Exploring complement biomarkers in suspected axial spondyloarthritis. RMD open 10 (2) (2024)
Jüergen Braun, Elisabeth Märker-Hermann, Martin Rudwaleit, Joachim Sieper
HLA-B27 and the role of specific T cell receptors in the pathogenesis of spondyloarthritis. Annals of the rheumatic diseases (2024)
Clara Mistegård Jørgensen, Anne Troldborg, Anne Gitte Loft, Steffen Thiel, Laura Spiller, Mikhail Protopopov, Valeria Rios Rodriguez, Burkhard Muche, Judith Rademacher, Anne-Katrin Weber, Susanne Lüders, Joachim Sieper, Denis Poddubnyy, Fabian Proft
Exploring complement biomarkers in suspected axial spondyloarthritis. RMD open 10 (2) (2024)
Fabian Proft, Murat Torğutalp, Burkhard Muche, Valeria Rios Rodriguez, Joachim Listing, Mikhail Protopopov, Judith Rademacher, Hildrun Haibel, Laura Spiller, Anne-Katrin Weber, Maryna Verba, Jan Brandt-Juergens, Uta Kiltz, Maren Sieburg, Swen Jacki, Joachim Sieper, Denis Poddubnyy
Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial. Annals of the rheumatic diseases 83 (5) (2024)
Fabian Proft, Murat Torğutalp, Burkhard Muche, Valeria Rios Rodriguez, Joachim Listing, Mikhail Protopopov, Judith Rademacher, Hildrun Haibel, Laura Spiller, Anne-Katrin Weber, Maryna Verba, Jan Brandt-Juergens, Uta Kiltz, Maren Sieburg, Swen Jacki, Joachim Sieper, Denis Poddubnyy
Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial. Annals of the rheumatic diseases 83 (5) (2024)
Fares Al Mohamad, Valeria Rios Rodriguez, Hildrun Haibel, Mikhail Protopopov, Judith Rademacher, Joachim Sieper, Murat Torğutalp, Henriette Käding, Fabian Proft, Denis Poddubnyy
Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs. RMD open 10 (1) (2024)
Jüergen Braun, Joachim Sieper
Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitis. RMD open 9 (3) (2023)
Désirée Mfm van der Heijde, Anna Moltó, Josef S Smolen, Jüergen Braun, Maxime Dougados, Floris A van Gaalen, Lianne S Gensler, Robert Davies Inman, Robert B M Landewe, Helena Marzo-Ortega, Victoria Navarro-Compán, Andri Phoka, Denis Poddubnyy, Mikhail Protopopov, John D Reveille, Martin Rudwaleit, Percival Sampaio-Barros, Alexandre Sepriano, Joachim Sieper, Filip E Van den Bosch, Irene van der Horst-Bruinsma, Pedro M Machado, Xenofon Baraliakos
Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature. Annals of the rheumatic diseases (2023)
Désirée Mfm van der Heijde, Atul Deodhar, Walter P Maksymowych, Joachim Sieper, Filip Van den Bosch, Tae Hwan Kim, Kishimoto Mitsumasa, Andrew J K Ostor, Bernard Combe, Yunxia Sui, Yuanyuan Duan, Peter K Wung, In-Ho Song
Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension. RMD open 8 (2) (2022)
Murat Torğutalp, Valeria Rios Rodriguez, Ani Dilbaryan, Fabian Proft, Mikhail Protopopov, Maryna Verba, Judith Rademacher, Hildrun Haibel, Joachim Sieper, Martin Rudwaleit, Denis Poddubnyy
Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis. Annals of the rheumatic diseases (2022)
Kay-Geert A Hermann, Katharina Ziegeler, Virginie Kreutzinger, Denis Poddubnyy, Fabian Proft, Dominik Deppe, Juliane Greese, Joachim Sieper, Torsten Diekhoff
What amount of structural damage defines sacroiliitis: a CT study. RMD open 8 (1) (2022)
Désirée Mfm van der Heijde, Xenofon Baraliakos, Joachim Sieper, Atul A Deodhar, Robert D Inman, Hideto Kameda, Xiaofeng Zeng, Yunxia Sui, Xianwei Bu, Aileen L Pangan, Peter Wung, In-Ho Song
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial. Annals of the rheumatic diseases 81 (11) (2022)
Xenofon Baraliakos, Mikkel Østergaard, Robert Gw Lambert, Iris Eshed, Pedro M Machado, Susanne Juhl Pedersen, Ulrich Weber, Manouk de Hooge, Joachim Sieper, Denis Poddubnyy, Martin Rudwaleit, Désirée Mfm van der Heijde, Robert B M Landewe, Walter P Maksymowych
MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group. Annals of the rheumatic diseases (2022)
Anne Boel, Miranda van Lunteren, Clementina López Medina, Joachim Sieper, Désirée Mfm van der Heijde, Floris A van Gaalen
Geographical prevalence of family history in patients with axial spondyloarthritis and its association with HLA-B27 in the ASAS-PerSpA study. RMD open 8 (1) (2022)
Denis Poddubnyy, Torsten Diekhoff, Xenofon Baraliakos, Kay-Geert A Hermann, Joachim Sieper
Diagnostic evaluation of the sacroiliac joints for axial spondyloarthritis: should MRI replace radiography? Annals of the rheumatic diseases 81 (11) (2022)
Clementina López Medina, Sylvie Chevret, Anna Moltó, Joachim Sieper, Tuncay Duruöz, Uta Kiltz, Bassel Elzorkany, Najia Hajjaj-Hassouni, Ruben Burgos-Vargas, José Maldonado-Cocco, Nelly Ziadé, Meghna Gavali, Victoria Navarro-Compan, Shue-Fen Luo, Alessandro Biglia, Kim Tae-Jong, Kishimoto Mitsumasa, Fernando M Pimentel-Santos, Jieruo Gu, Laura Muntean, Floris A van Gaalen, Pál Geher, Marina Magrey, Sebastián E Ibáñez-Vodnizza, Wilson Bautista Molano, Walter P Maksymowych, Pedro M Machado, Robert B M Landewe, Désirée Mfm van der Heijde, Maxime Dougados
Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study. RMD open 7 (3) (2022)
Berthold Hoppe, Christian Schwedler, Hildrun Haibel, Maryna Verba, Fabian Proft, Mikhail Protopopov, Hans-Gert Heuft, Valeria Rios Rodriguez, Anke Edelmann, Martin Rudwaleit, Joachim Sieper, Denis Poddubnyy
Predictive value of C-reactive protein for radiographic spinal progression in axial spondyloarthritis in dependence on genetic determinants of fibrin clot formation and fibrinolysis. RMD open 7 (2) (2021)
Clementina López Medina, Anna Moltó, Joachim Sieper, Tuncay Duruöz, Uta Kiltz, Bassel Elzorkany, Najia Hajjaj-Hassouni, Ruben Burgos-Vargas, José Maldonado-Cocco, Nelly Ziadé, Meghna Gavali, Victoria Navarro-Compan, Shue-Fen Luo, Sara Monti, Kim Tae-Jong, Mitsumasa Kishimoto, F M Pimentel-Santos, Jieruo Gu, Ruxandra Schiotis, Floris A van Gaalen, Pál Geher, Marina Magrey, Sebastián Eduardo Ibáñez Vodnizza, Wilson Bautista Molano, Walter Maksymowych, Pedro M Machado, Robert Landewé, Désirée Mfm van der Heijde, Maxime Dougados
Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study. RMD open 7 (1) (2021)
Joachim Sieper, Denis Poddubnyy
What is the optimal target for a T2T approach in axial spondyloarthritis? Annals of the rheumatic diseases 80 (11) (2021)
Clementina López Medina, Sofia Ramiro, Désirée Mfm van der Heijde, Joachim Sieper, Maxime Dougados, Anna Moltó
Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis. RMD open 5 (2) (2019)
Joachim Sieper, Robert Landewé, Marina Magrey, Jaclyn K Anderson, Sheng Zhong, Xin Wang, Apinya Lertratanakul
Predictors of remission in patients with non-radiographic axial spondyloarthritis receiving open-label adalimumab in the ABILITY-3 study. RMD open 5 (1) (2019)